Up 64% in a month, here's why the Novonix (ASX:NVX) share price is supercharging right now

It's been a crazy month for Novonix shareholders…

| More on:
Businessman taking off in rocket-fuelled office chair

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Novonix Ltd (ASX: NVX) share price is roaring higher over the last month despite the company being relatively quiet.

Novonix's one and only price-sensitive release of the last 30 days dropped last week. It detailed the company's quarterly activities and cash flows.

On top of that, the Novonix share price had seemingly been riding a recent wave of enthusiasm for lithium. While Novonix doesn't deal directly with lithium, it works in the battery technology space.

Finally, news of Telsa Inc (NASDAQ: TSLA) may have piqued the market's interest in Novonix due to its leader's ties with the electric car manufacture. Last week, Tesla celebrated a significant milestone when its value surpassed US$1 trillion.

On Thursday, the Novonix share price closed at $8.54, 1.78% higher than its previous close and 64.5% higher than it was this time last month.

Let's take a closer look at what might be moving the graphite explorer and manufacturer's stock lately.

What could be fuelling the Novonix share price?

The only release the market has seen from Novonix over the last month was its activities and cash flow report for the September quarter. The Novonix share price rallied 8.5% on the day the company released its quarterly results.

Over the quarter just been, Novonix saw a loss of $6.9 million. It ended the period with around $290.9 million in cash and approximately $48.8 million of drawn finance.

That's enough to fund another 42.2 quarters if costs remain the same as the one just been.

Additionally, over the quarter just been, Novonix purchased a new battery anode production facility in the United States. It also saw Phillips 66 (NYSE: PSX) make a strategic investment in the company.

Excitingly, it also welcomed its new chief scientific advisor, Professor Jeff Dahn.

Dahn and his research group have an exclusive partnership with Tesla. For those who aren't aware, Dahn is the second connection Novonix has with Tesla.

The company's CEO, Dr Chris Burns, was previously Tesla's senior research engineer.

Finally, the Novonix share price's recent rally might be due to increased interest in battery technology companies and lithium producers.

Lithium stocks surged last week alongside the commodity's price. While Novonix doesn't deal in lithium itself, its stock tends to move alongside lithium shares, likely due to its involvement in the battery sector.

The continued upwards movement experienced by the Novonix share price could be a signal of the market's lasting excitement in the battery sector.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »